Interactive Drug Benefit List
DIN/NPN/ PIN
Generic Name
Product Name, Strength & Dosage Form
Unit Price, Unit of Issue
Manufacturer
LCA Price
MAC Price
Interchangeable Products
Coverage Status
02298805
APREPITANT
EMEND 125 MG ORAL CAPSULE
N/A CAP
MFC
N/A
N/A
NO
NOT A BENEFIT
Details
02298791
APREPITANT
EMEND 80 MG ORAL CAPSULE
35.6613 CAP
MFC
N/A
N/A
NO
RESTRICTED BENEFIT
Details
02298813
APREPITANT/ APREPITANT
EMEND TRI-PACK 80 MG * 125 MG ORAL CAPSULE
35.6613 CAP
MFC
N/A
N/A
NO
RESTRICTED BENEFIT
Details
02413248
DOXYLAMINE SUCCINATE/ PYRIDOXINE HCL
APO-DOXYLAMINE/B6 10 MG * 10 MG ORAL SUSTAINED-RELEASE TABLET
0.6402 TAB
APX
0.6402
N/A
YES
REGULAR BENEFIT
Details
00609129
DOXYLAMINE SUCCINATE/ PYRIDOXINE HCL
DICLECTIN 10 MG * 10 MG ORAL SUSTAINED-RELEASE TABLET
1.2803 TAB
DUI
0.6402
N/A
YES
REGULAR BENEFIT
Details
02406187
DOXYLAMINE SUCCINATE/ PYRIDOXINE HCL
PMS-DOXYLAMINE-PYRIDOXINE 10 MG * 10 MG ORAL SUSTAINED-RELEASE TABLET
0.6402 TAB
PMS
0.6402
N/A
YES
REGULAR BENEFIT
Details
02312263
NABILONE
CESAMET 0.25 MG ORAL CAPSULE
N/A CAP
VCL
N/A
N/A
NO
NOT A BENEFIT
Details
02256193
NABILONE
CESAMET 0.5 MG ORAL CAPSULE
3.8043 CAP
VCL
1.8886
N/A
YES
REGULAR BENEFIT
Details
02380900
NABILONE
PMS-NABILONE 0.5 MG ORAL CAPSULE
1.8886 CAP
PMS
1.8886
N/A
YES
REGULAR BENEFIT
Details
02384884
NABILONE
TEVA-NABILONE 0.5 MG ORAL CAPSULE
1.8886 CAP
TEV
1.8886
N/A
YES
REGULAR BENEFIT
Details
00548375
NABILONE
CESAMET 1 MG ORAL CAPSULE
7.6082 CAP
VCL
3.6669
N/A
YES
REGULAR BENEFIT
Details
02380919
NABILONE
PMS-NABILONE 1 MG ORAL CAPSULE
3.6669 CAP
PMS
3.6669
N/A
YES
REGULAR BENEFIT
Details
02384892
NABILONE
TEVA-NABILONE 1 MG ORAL CAPSULE
3.6669 CAP
TEV
3.6669
N/A
YES
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02298805
Generic Name
APREPITANT
Product Name, Strength & Dosage Form
EMEND 125 MG ORAL CAPSULE
Unit Price, Unit of Issue
N/A
Manufacturer
MFC
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
NOT A BENEFIT
Details
DIN/NPN/ PIN
02298791
Generic Name
APREPITANT
Product Name, Strength & Dosage Form
EMEND 80 MG ORAL CAPSULE
Unit Price, Unit of Issue
35.6613
Manufacturer
MFC
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
RESTRICTED BENEFIT
Details
DIN/NPN/ PIN
02298813
Generic Name
APREPITANT/ APREPITANT
Product Name, Strength & Dosage Form
EMEND TRI-PACK 80 MG * 125 MG ORAL CAPSULE
Unit Price, Unit of Issue
35.6613
Manufacturer
MFC
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
RESTRICTED BENEFIT
Details
DIN/NPN/ PIN
02413248
Generic Name
DOXYLAMINE SUCCINATE/ PYRIDOXINE HCL
Product Name, Strength & Dosage Form
APO-DOXYLAMINE/B6 10 MG * 10 MG ORAL SUSTAINED-RELEASE TABLET
Unit Price, Unit of Issue
0.6402
Manufacturer
APX
LCA Price
0.6402
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
00609129
Generic Name
DOXYLAMINE SUCCINATE/ PYRIDOXINE HCL
Product Name, Strength & Dosage Form
DICLECTIN 10 MG * 10 MG ORAL SUSTAINED-RELEASE TABLET
Unit Price, Unit of Issue
1.2803
Manufacturer
DUI
LCA Price
0.6402
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02406187
Generic Name
DOXYLAMINE SUCCINATE/ PYRIDOXINE HCL
Product Name, Strength & Dosage Form
PMS-DOXYLAMINE-PYRIDOXINE 10 MG * 10 MG ORAL SUSTAINED-RELEASE TABLET
Unit Price, Unit of Issue
0.6402
Manufacturer
PMS
LCA Price
0.6402
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02312263
Generic Name
NABILONE
Product Name, Strength & Dosage Form
CESAMET 0.25 MG ORAL CAPSULE
Unit Price, Unit of Issue
N/A
Manufacturer
VCL
LCA Price
N/A
MAC Price
N/A
Interchangeable Products
NO
Coverage Status
NOT A BENEFIT
Details
DIN/NPN/ PIN
02256193
Generic Name
NABILONE
Product Name, Strength & Dosage Form
CESAMET 0.5 MG ORAL CAPSULE
Unit Price, Unit of Issue
3.8043
Manufacturer
VCL
LCA Price
1.8886
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02380900
Generic Name
NABILONE
Product Name, Strength & Dosage Form
PMS-NABILONE 0.5 MG ORAL CAPSULE
Unit Price, Unit of Issue
1.8886
Manufacturer
PMS
LCA Price
1.8886
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02384884
Generic Name
NABILONE
Product Name, Strength & Dosage Form
TEVA-NABILONE 0.5 MG ORAL CAPSULE
Unit Price, Unit of Issue
1.8886
Manufacturer
TEV
LCA Price
1.8886
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
00548375
Generic Name
NABILONE
Product Name, Strength & Dosage Form
CESAMET 1 MG ORAL CAPSULE
Unit Price, Unit of Issue
7.6082
Manufacturer
VCL
LCA Price
3.6669
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02380919
Generic Name
NABILONE
Product Name, Strength & Dosage Form
PMS-NABILONE 1 MG ORAL CAPSULE
Unit Price, Unit of Issue
3.6669
Manufacturer
PMS
LCA Price
3.6669
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
DIN/NPN/ PIN
02384892
Generic Name
NABILONE
Product Name, Strength & Dosage Form
TEVA-NABILONE 1 MG ORAL CAPSULE
Unit Price, Unit of Issue
3.6669
Manufacturer
TEV
LCA Price
3.6669
MAC Price
N/A
Interchangeable Products
YES
Coverage Status
REGULAR BENEFIT
Details
GLOSSARY
To return to the printable Drug Benefit List and related publications,
click here
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.
Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL) , and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.